A disproportionately greater body weight of the recipient in regards to the donor causes chronic graft nephropathy. A study of paired kidneys

Nephrology Dialysis Transplantation

Volumn 19, Issue SUPPL. 3, 2004, Pages

  Andrés, Amado ^a   Mazuecos, Auxiliadora ^b   García Doncel, Ana García ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Chronic nephropathy; Donor weight; Hyperfiltration; Recipient weight; Renal transplantation

Indexed keywords

ANTIBODY; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CREATININE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ACUTE GRAFT REJECTION; ARTICLE; BODY WEIGHT; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; GRAFT SURVIVAL; HUMAN; HYPERTENSION; KIDNEY ALLOGRAFT REJECTION; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROTEINURIA; RECIPIENT; RISK FACTOR; SURVIVAL TIME;

ADULT; BODY WEIGHT; CHRONIC DISEASE; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; SURVIVAL RATE; TIME FACTORS; TISSUE DONORS;

EID: 3242667179     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh1010     Document Type: Article

References (22)

1. European Mycophenolate Mofetil Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995; 345: 1321-1325
2. Mayer A, Dmitrewski J, Squifflet J et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation 1997; 64: 436-443
3. Hariharan S, Johnson CP, Bresnahan BA, Taranto, SE, Mcintosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-612
4. Paul LC, Fellstrom B. Chronic vascular rejection of the heart and kidney have rational treatment options emerged? Transplantation 1992; 53: 1169-1179
5. Matas AJ, Burke JF, DeVault GA et al. Chronic rejection. J Am Soc Nephrol 1994; 4: S23-S29
6. Brenner BM, Cohen RA, Milford EL. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992; 3: 162-169
7. Harmon WE, Jabs K. Special issues in pediatric renal transplantation. Semin Nephrol 1992; 12: 353-363
8. Alexander JW, Bennett LE, Breen TJ. Effects of donor age on outcome of kidney transplantation. Transplantation 1994: 57; 871-876
9. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S. Fit and match hypothesis for kidney transplantation. Transplantation 1996; 62: 441-445
10. Moreso F, Seron D, Anunciada AI et al. Recipient body surface area as a predictor of posttransplant renal allograft evolution. Transplantation 1998; 65: 671-676
11. Kasiske BL, Snyder JJ, Gilbertson D. Inadequate donor size in cadaver kidney transplantation. J Am Soc Nephrol 2002; 13: 2152-2159
12. Praga M. Nefropatía por hiperfiltración. Nefrología 2000; 20: 311-335
13. Paul LC. Chronic renal transplant loss. Kidney Int 1995; 47: 1491-1499
14. Giatras I, Lau J, Levey A. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Ann Intern Med 1997; 127: 337-345
15. Brenner B, Cooper ME, Zeeuw D et al. Effects of Losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869
16. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R Andersen S, Arner P. The effect of Irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345: 870-878
17. Cho YW, Cecka JM, Terasaki PI. HLA matching effect: better survival rates and graft quality. In: Terasaki PI, Cecka JM, eds. Clinical Transplants 1994. UCLA Tissue Typing Laboratory, Los Angeles: 1995; 435.
18. Opelz G, Wujciak T, Mytilineos J, Scherer S. Revisiting HLA matching for kidney transplantation. Transplant Proc 1993; 25: 173-175
19. Andrés A, Morales JM, Herrero JC et al. Double versus single renal allograft from aged donors. Transplantation 2000; 69: 2064-2066
20. Kaplan C, Paternack B, Shah H, Gallo G. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 1975; 80: 227-229
21. Macias JF. Aspectos morfológicos, funcionales y patológicos del riñón del viejo. Nefrología 1983; 3: 1-7
22. Cecka JM, Terasaki PI. Optimal use for older donor kidneys: older recipients. Transplant Proc 1995; 27: 801-802